Next Article in Journal
Real-World Clinical Outcomes of Ribociclib in Combination with a Non-Steroidal Aromatase Inhibitor and a Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal HR+/HER2− Advanced Breast Cancer Patients: An Italian Managed Access Program
Next Article in Special Issue
Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study
Previous Article in Journal
Comparison of Efficacy and Safety of Taxanes Plus Platinum and Fluorouracil Plus Platinum in the First-Line Treatment of Esophageal Cancer: A Systematic Review and Meta-Analysis
Previous Article in Special Issue
Neoadjuvant Immunotherapy Combined with Chemotherapy for Local Advanced Non-Small-Cell Lung Cancer in a Patient with a History of Breast Cancer: A Case Report
 
 
Case Report

Article Versions Notes

Curr. Oncol. 2022, 29(9), 6628-6634; https://doi.org/10.3390/curroncol29090520
Action Date Notes Link
article pdf uploaded. 16 September 2022 16:23 CEST Version of Record https://www.mdpi.com/1718-7729/29/9/520/pdf-vor
article pdf uploaded. 16 September 2022 16:25 CEST Updated version of record https://www.mdpi.com/1718-7729/29/9/520/pdf-vor
article xml file uploaded 21 September 2022 10:30 CEST Original file -
article xml uploaded. 21 September 2022 10:30 CEST Update -
article pdf uploaded. 21 September 2022 10:30 CEST Updated version of record https://www.mdpi.com/1718-7729/29/9/520/pdf-vor
article html file updated 21 September 2022 10:48 CEST Original file -
article xml file uploaded 22 September 2022 02:45 CEST Update -
article xml uploaded. 22 September 2022 02:45 CEST Update https://www.mdpi.com/1718-7729/29/9/520/xml
article pdf uploaded. 22 September 2022 02:45 CEST Updated version of record https://www.mdpi.com/1718-7729/29/9/520/pdf
article html file updated 22 September 2022 02:46 CEST Update -
article html file updated 22 September 2022 10:01 CEST Update https://www.mdpi.com/1718-7729/29/9/520/html
Back to TopTop